Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen M Westerhout

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Cancer Research|December 2, 2021
Mesenchymal-Type Neuroblastoma Cells Escape ALK InhibitorsEllen M Westerhout, Mohamed Hamdi, Peter Stroeken, et al.
Nature|February 28, 2012
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genesJan J Molenaar, Jan Koster, Danny A Zwijnenburg, et al.
Oncogene|December 13, 2018
ALK positively regulates MYCN activity through repression of HBP1 expressionShana Claeys, Geertrui Denecker, Kaat Durinck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2010
Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplificationSara De Brouwer, Katleen De Preter, Candy Kumps, et al.
Nature Genetics|June 27, 2017
Neuroblastoma is composed of two super-enhancer-associated differentiation statesTim van Groningen, Jan Koster, Linda J Valentijn, et al.
Nature Genetics|June 30, 2015
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutationsThomas F Eleveld, Derek A Oldridge, Virginie Bernard, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Cancer Research|December 2, 2021
Mesenchymal-Type Neuroblastoma Cells Escape ALK InhibitorsEllen M Westerhout, Mohamed Hamdi, Peter Stroeken, et al.
Nature|February 28, 2012
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genesJan J Molenaar, Jan Koster, Danny A Zwijnenburg, et al.
Oncogene|December 13, 2018
ALK positively regulates MYCN activity through repression of HBP1 expressionShana Claeys, Geertrui Denecker, Kaat Durinck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2010
Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplificationSara De Brouwer, Katleen De Preter, Candy Kumps, et al.
Nature Genetics|June 27, 2017
Neuroblastoma is composed of two super-enhancer-associated differentiation statesTim van Groningen, Jan Koster, Linda J Valentijn, et al.
Nature Genetics|June 30, 2015
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutationsThomas F Eleveld, Derek A Oldridge, Virginie Bernard, et al.
Pageof 3